Insider · CIK 0001429559

Lafond Kevin G

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001429559

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-01-08	TCRTAlaunos Therapeutics, Inc.S Sale	SVP, Treasurer & CAO	SSale	−18K sh	$3.09	−$55.7K	63,965
2020-01-29	TCRTAlaunos Therapeutics, Inc.A Award	SVP, Treasurer & CAO	AAward	+18K sh	—	—	81,985
2020-01-02	TCRTAlaunos Therapeutics, Inc.S Sale	SVP, Treasurer & CAO	SSale	−21.6K sh	$4.55	−$98.1K	63,985
2019-12-31	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	SVP, Treasurer & CAO	AAward	+48K sh	—	—	48,000
2019-11-26	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	SVP, Treasurer & CAO	MExercise/Conversion	+11.7K sh	$2.85	+$33.3K	97,222
2019-11-26	TCRTAlaunos Therapeutics, Inc.S Sale	SVP, Treasurer & CAO	SSale	−11.7K sh	$5.25	−$61.3K	85,555
2019-11-26	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP, Treasurer & CAO	MExercise/Conversion	−11.7K sh	—	—	0
2019-01-06	TCRTAlaunos Therapeutics, Inc.A Award	SVP, Treasurer & CAO	AAward	+37.1K sh	—	—	85,555
2019-01-06	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	SVP, Treasurer & CAO	AAward	+58.5K sh	—	—	58,536
2018-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	SVP, Treasurer & CAO	FTax Payment	−9,334 sh	$1.87	−$17.5K	48,433
2018-12-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	SVP, Treasurer & CAO	FTax Payment	−13.1K sh	$1.66	−$21.7K	57,767
2018-12-29	TCRTAlaunos Therapeutics, Inc.F Tax Payment	SVP, Treasurer & CAO	FTax Payment	−17.7K sh	$1.66	−$29.3K	70,867
2017-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	SVP, Treasurer & CAO	FTax Payment	−9,333 sh	$4.14	−$38.6K	88,534
2017-12-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	SVP, Treasurer & CAO	FTax Payment	−13.1K sh	$4.14	−$54.2K	97,867
2017-12-29	TCRTAlaunos Therapeutics, Inc.A Award	SVP, Treasurer & CAO	AAward	+53K sh	—	—	110,967
2016-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	SVP, Treasurer & CAO	FTax Payment	−9,333 sh	$5.35	−$49.9K	57,967
2016-12-30	TCRTAlaunos Therapeutics, Inc.A Award	SVP, Treasurer & CAO	AAward	+39.3K sh	—	—	67,300
2015-12-31	TCRTAlaunos Therapeutics, Inc.A Award	SVP, Treasurer & CAO	AAward	+28K sh	—	—	28,000
2015-06-03	TCRTAlaunos Therapeutics, Inc.S Sale	SVP, Treasurer & CAO	SSale	−26.7K sh	$9.60	−$256K	0
2015-06-03	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	SVP, Treasurer & CAO	MExercise/Conversion	+3,334 sh	$0.80	+$2,667.2	3,334
2015-06-03	TCRTAlaunos Therapeutics, Inc.S Sale	SVP, Treasurer & CAO	SSale	−3,334 sh	$9.70	−$32.3K	0
2015-06-03	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	SVP, Treasurer & CAO	MExercise/Conversion	+27.5K sh	$2.30	+$63.2K	27,500
2015-06-03	TCRTAlaunos Therapeutics, Inc.S Sale	SVP, Treasurer & CAO	SSale	−27.5K sh	$9.70	−$267K	0
2015-06-03	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, Treasurer & CAO	MExercise/Conversion	−3,334 sh	—	—	0
2015-06-03	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, Treasurer & CAO	MExercise/Conversion	−27.5K sh	—	—	55,000
2014-12-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP, Treasurer & CAO	AAward	+75K sh	—	—	75,000
2014-12-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	SVP, Treasurer & CAO	FTax Payment	−4,690 sh	$5.03	−$23.6K	26,666
2013-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	SVP, Treasurer & CAO	FTax Payment	−4,690 sh	$4.34	−$20.4K	31,356
2013-12-31	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP, Treasurer & CAO	AAward	+35K sh	—	—	35,000
2013-06-27	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	SVP, Treasurer & CAO	AAward	+82.5K sh	—	—	82,500

Recent filings

Accepted (ET)
Jan 124
Lafond Kevin G0001209191-21-003244
SEC(opens sec.gov)
Jan 314
Lafond Kevin G0001209191-20-005785
SEC(opens sec.gov)
Jan 34
Lafond Kevin G0001209191-20-001176
SEC(opens sec.gov)
Nov 274
Lafond Kevin G0001209191-19-058365
SEC(opens sec.gov)
Jan 84
Lafond Kevin G0001209191-19-002787
SEC(opens sec.gov)
Jan 24
Lafond Kevin G0001209191-19-000588
SEC(opens sec.gov)
Jan 34
Lafond Kevin G0001209191-18-001005
SEC(opens sec.gov)
Jan 44
ZIOPHARM ONCOLOGY INC0001209191-17-001003
SEC(opens sec.gov)
Jan 54
ZIOPHARM ONCOLOGY INC0001209191-16-088692
SEC(opens sec.gov)
Jun 54
ZIOPHARM ONCOLOGY INC0001209191-15-050757
SEC(opens sec.gov)

Companies

Alaunos Therapeutics, Inc.SVP, Treasurer & CAOTCRT

Address

C/O ZIOPHARM ONCOLOGY, INC. 1 FIRST AVE. PARRIS BLDG. #34, NAVY YARD

BOSTON, MA, 02129